Sugi Predict

Sugi Predict / Compounds / SCHEMBL3970919

SCHEMBL3970919

SCHEMBL3970919

Cc1cc(/C=C/C(=O)c2ccc(F)cc2)cc(C)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TNFRSF1A P19438 1/20 0.65
▸ ALOX5 P09917 1/20 0.63
▸ PTGS1 P23219 1/20 0.63
▸ PTGS2 P35354 1/20 0.63
▸ ALDH1A1 P00352 1/20 0.59
▸ KRAS P01116 1/20 0.59
▸ ATM Q13315 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970921 1.00 TNFRSF1A (0.65) TNFRSF1AALOX5PTGS1PTGS2ALDH1A1
SCHEMBL13359041 0.87 MAPT (0.66) —
SCHEMBL29151961 0.86 TTR (0.59) —
SCHEMBL29151956 0.86 TTR (0.59) —
SCHEMBL28606022 0.85 MAPT (0.64) ALDH1A1SMN1; SMN2
SCHEMBL28606020 0.85 MAPT (0.64) ALDH1A1SMN1; SMN2
SCHEMBL498894 0.84 MAOB (0.65) ALOX5PTGS1PTGS2
SCHEMBL498634 0.84 ESR1 (0.62) KRAS
SCHEMBL498895 0.84 MAOB (0.65) ALOX5PTGS1PTGS2
SCHEMBL498633 0.84 ESR1 (0.62) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113230240-B 1,3-diphenylprop-2-en-1-one derivative and application thereof 广州医科大学 2022-12-27 — — CN disclosed
CN-113230240-A 1, 3-diphenylprop-2-en-1-one derivative and application thereof 广州医科大学 2021-08-10 — — CN disclosed
US-7566737-B2 Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2009-07-28 — — US disclosed
US-7566737-B2 Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2009-07-28 — — US disclosed
US-7566737-B2 Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2009-07-28 — — US disclosed
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2007-02-08 — — US disclosed
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2007-02-08 — — US disclosed
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients GENFIT (FR) 2007-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032543-A1 Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients PSEN1, BACE1, PSEN2 TNFRSF1A 2548/4885ALOX5 479/4885PTGS1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.